Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observer-blind Immunogenicity Study of GSK Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects

NCT00765076 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00765076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00765076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observer-blind Immunogenicity Study of GSK Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 16, 2008
Completion date
December 4, 2009
Enrollment
192 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

influenza